Recap: Planet Labs Q3 Earnings

Planet Labs (NYSE:PL) reported its Q3 earnings results on Thursday, December 7, 2023 at 04:05 PM. Here’s what…

Planet Labs (NYSE:PL) reported its Q3 earnings results on Thursday, December 7, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Planet Labs missed estimated earnings by 62.5%, reporting an EPS of $-0.13 versus an estimate of $-0.08.

Revenue was up $5.68 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 11.04% drop in the share price the next day.

Here’s a look at Planet Labs’s past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.08 -0.15 -0.16 -0.17
EPS Actual -0.14 -0.13 -0.14 -0.15
Revenue Estimate 54.14M 52.91M 52.56M 47.20M
Revenue Actual 53.76M 52.70M 52.98M 49.70M

To track all earnings releases for Planet Labs visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Ultragenyx Reports Preliminary 2023 Revenue; Guidance For 2024 Revenue And Cash Usage; Pipeline Updates And 2024 Milestones; Sees FY23 Revenue $430-$435M Vs $435.9M Est.; Sees FY24 Revenue $500M-$530M Vs $523.86M Est.; Year-End 2023 Cash Balance Of ~$7…

Preliminary 2023 Total Revenue of $430 million to $435 million, Crysvita® Revenue of $325 million to $330 million and Dojolvi® revenue of $70 million to $71 million2024 expected Total Revenue guidance

RARE